Disclosure Insight

UPDATE: Disclosure Insight Downgrades Integra Lifesciences to Medium Risk - Negative Bias
UPDATE: Disclosure Insight Downgrades Alpha Natural Resources to Medium Risk - Negative Bias
UPDATE: Disclosure Insight Downgrades Agco to Medium Risk - Negative Bias
UPDATE: Disclosure Insight Downgrades Alpha Natural Resources to Medium Risk - Negative Bias
UPDATE: Disclosure Insight Downgrades Agco to Medium Risk - Negative Bias
UPDATE: Disclosure Insight Downgrades Alexion Pharmaceuticals to Medium Risk - Negative Bias
UPDATE: Disclosure Insight Upgrades Computer Programs & Systems to Medium Risk - Positive Bias

Disclosure Insight Recent News

Disclosure Insight Maintains Medium Risk Rating on JDA Software Group
Disclosure Insight Maintains Medium Risk Rating on GP Strategies
UPDATE: Disclosure Insight Downgrades Exco Resources Inc. to High Risk
Disclosure Insight Maintains Medium Risk Rating on DR Horton
Disclosure Insight Maintains Medium Risk Rating on Comtech Telecommunications Corp.
Disclosure Insight Maintains Medium Risk Rating on Cisco Systems
Disclosure Insight Maintains Medium Risk Rating on Ball Corp.
Disclosure Insight Maintains Medium Risk Rating on Applies Industrial Technologies
Disclosure Insight Maintains Medium Risk Rating on Zions Bancorp
Disclosure Insight Maintains Medium Risk Rating on Vector Group
Disclosure Insight Maintains Medium Risk Rating on Universal Forest Products
Disclosure Insight Maintains Medium Risk Rating on Ryland Group
Disclosure Insight Maintains Medium Risk Rating on Omnicell
Disclosure Insight Maintains Medium Risk Rating on Nektar Therapeutics
Disclosure Insight Maintains Medium Risk Rating on Nasdaq OMX Group
Disclosure Insight Maintains Medium Risk Rating on Luminex
Disclosure Insight Maintains Medium Risk Rating on Knology
Disclosure Insight Maintains Medium Risk Rating on JAKKS Pacific
Disclosure Insight Maintains Medium Risk Rating on j2 Global Communications
Disclosure Insight Maintains Medium Risk Rating on Great Lakes Dredge & Dock Corp.
Disclosure Insight Maintains Medium Risk Rating on Dollar Tree
Disclosure Insight Maintains Medium Risk Rating on Cadence Pharmaceuticals
Disclosure Insight Upgrades Rating to Medium Risk Positive Bias on Apple